Delivery Order SPE2DB22D1106-SPE2DB25FEYD4
Award Date 7/16/25
Potential Completion Date 8/6/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $5,078.08 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 mg-600 mg suspension in 4 mL formulation, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, reflecting the breadth of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,169 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg-900 mg suspension (6 mL) on August 22, 2025. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. CABENUVA is a long-acting injectable antiretroviral medication used in HIV treatment, representing the company's...
- The Defense Logistics Agency awarded a $38,169.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), with an ultimate completion date of May 15, 2025. This non-set-aside competitive award represents a child delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to...
- The Defense Logistics Agency awarded a $7,633.80 delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL) with a firm fixed price structure and an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract represents a single delivery order executed on July 30, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. CABENUVA is an injectable antiretroviral...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $3,816.90 to supply CABENUVA ER 600 MG-900 MG Suspension 6ML, a long-acting injectable antiretroviral medication used for HIV treatment. This firm fixed price, competitively awarded delivery order is scheduled for completion by July 14, 2025, and is being performed from AmerisourceBergen's location in Conshohocken, Pennsylvania. The contract is part of the company's broader pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a $5,078.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for CABENUVA ER 400 MG-600 MG suspension (4 mL), with an ultimate completion date of August 6, 2025. This is a non-set-aside competitive award issued on July 16, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,535.20 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting antiretroviral combination medication used in HIV treatment. Issued on September 14, 2025, with an ultimate completion date of October 3, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement under a competitive award with no set-aside designation. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $34,352.10 to AmerisourceBergen Drug Corp for CABENUVA ER 600 MG-900 MG suspension (6 mL), a long-acting injectable antiretroviral medication used in HIV treatment. This firm fixed-price delivery order, issued on June 2, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The contract carries...
- The Defense Logistics Agency awarded a delivery order valued at $38,169.00 to AmerisourceBergen Drug Corp for CABENUVA ER 600 mg–900 mg suspension (6 mL) with a completion date of September 30, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a...
- The Defense Logistics Agency Medical Supply Chain awarded a $38,169 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for CABENUVA ER 600 MG-900 MG Suspension in 6 mL units. This firm fixed-price delivery order, which represents a child contract action under AmerisourceBergen's larger pharmaceutical supply agreements, is scheduled for completion by September 18, 2025, with performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with...